RecruitingNCT05102799
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
Sponsor
Rigshospitalet, Denmark
Enrollment
200 participants
Start Date
Apr 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying No intervention for people with limb girdle muscular dystrophy. The study is currently recruiting participants at 1 location.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo intervention
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05102799
Related Trials
Telecare Psychosocial and Cognitive Intervention for Children and Adolescents With Limb-Girdle Muscular Dystrophy
NCT077117301 location
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
NCT052304596 locations
LGMD R1 Natural History Study
NCT0561808012 locations
Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]
NCT063782031 location
Molecular Analysis of Patients With Neuromuscular Disease
NCT003901041 location